In preclinical models studying S. aizoon extracts, what specific improvements were noted regarding metabolic health?
Regulation of blood lipids, lowering total cholesterol (TC) and triglycerides (TG) while raising beneficial HDL-C levels
Scientific research has provided laboratory evidence supporting the systemic health benefits traditionally associated with Sedum aizoon. In preclinical models designed to mimic hyperlipidemia (abnormally high levels of fats/lipids in the blood), extracts demonstrated a clear ability to regulate metabolic parameters. This regulation involved actively lowering adverse lipid markers, specifically total cholesterol (TC) and triglycerides (TG). Crucially, this beneficial effect was accompanied by an increase in high-density lipoprotein cholesterol (HDL-C), widely regarded as the beneficial type of cholesterol, suggesting a positive influence on systemic lipid management.
